Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kymera Therapeutics (KYMR) Return on Assets (2020 - 2025)

Historic Return on Assets for Kymera Therapeutics (KYMR) over the last 6 years, with Q3 2025 value amounting to 0.3%.

  • Kymera Therapeutics' Return on Assets fell 800.0% to 0.3% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.3%, marking a year-over-year decrease of 800.0%. This contributed to the annual value of 0.34% for FY2024, which is 600.0% down from last year.
  • As of Q3 2025, Kymera Therapeutics' Return on Assets stood at 0.3%, which was down 800.0% from 0.3% recorded in Q2 2025.
  • In the past 5 years, Kymera Therapeutics' Return on Assets ranged from a high of 0.1% in Q1 2021 and a low of 0.33% during Q3 2023
  • Its 5-year average for Return on Assets is 0.24%, with a median of 0.26% in 2022.
  • As far as peak fluctuations go, Kymera Therapeutics' Return on Assets tumbled by -1300bps in 2022, and later surged by 1100bps in 2024.
  • Kymera Therapeutics' Return on Assets (Quarter) stood at 0.16% in 2021, then crashed by -61bps to 0.26% in 2022, then dropped by -13bps to 0.29% in 2023, then rose by 11bps to 0.26% in 2024, then decreased by -14bps to 0.3% in 2025.
  • Its last three reported values are 0.3% in Q3 2025, 0.3% for Q2 2025, and 0.29% during Q1 2025.